Whitehawk Therapeutics Inc <WHWK.O>: Leerink Partners initiates coverage with outperform rating; target price $9
WHWK•Related News
Alto Neuroscience estimates June 30 cash, equivalents and restricted cash at $244.2 million
ANRO•
Acurx Pharmaceuticals posts presentation on ibezapolstat microbiome restoration potential in recurrent C. difficile infection
ACXP•
UK supermarket Morrisons in talks for $803 million stores deal, Sky News reports
O•
Deep Fission, Inc <FISN.O>: Benchmark initiates coverage with buy rating; target price $20
FISN•
Nuburu plans up to USD 38 million premium-priced offering to fund controlling stake in Tekne
BURU•